Tickers

1. Composite Trajectory Verdict

For a bank, the income statement and balance sheet carry the most weight because they directly reflect net interest margin trends, credit quality, and capital adequacy, while cash flow is largely a byproduct of deposit funding and asset growth.

Composite Trajectory: Mixed

Net income and net interest income grew year-over-year, and the efficiency ratio improved on a GAAP basis. However, asset quality deteriorated sharply: nonperforming loans nearly doubled, nonperforming assets more than tripled, and classified assets more than doubled. The allowance coverage of nonperforming loans fell by roughly half. Capital ratios declined modestly but remain well above regulatory minimums. Operating cash flow has declined for three consecutive years. The noninterest income boost includes a $32.1 million anticipated insurance recovery tied to a solar tax credit recapture, which is non-recurring. These opposing trends produce a mixed overall trajectory.

2. Red Flags

• Nonperforming loans increased 94% to $82.8 million (10-K 2025-12-31, MD&A Nonperforming loans and assets), and nonperforming assets rose 252% to $164.4 million (10-K 2025-12-31, MD&A Nonperforming loans and assets).
• Classified assets more than doubled to $410.5 million from $193.8 million (10-K 2025-12-31, MD&A Financial Performance Highlights).
• Allowance for credit losses coverage of nonperforming loans fell from 323% to 169% (10-K 2025-12-31, MD&A Nonperforming loans and assets).
• Net charge-offs rose 39% to $24.3 million (10-K 2025-12-31, MD&A Provision and ACL).
• Noninterest income includes $32.1 million of anticipated insurance proceeds from a pending claim related to a solar tax credit recapture (10-K 2025-12-31, MD&A Noninterest Income).
• The Company recorded a $24.1 million tax credit recapture and approximately $8.0 million of incremental tax liability attributable to the anticipated insurance proceeds (10-K 2025-12-31, MD&A Income Taxes).
• Operating cash flow declined for the third straight year: $193.5 million in 2025 vs. $247.4 million in 2024 and $268.2 million in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Core efficiency ratio (non-GAAP) worsened to 59.32% from 58.42% (10-K 2025-12-31, MD&A Use of Non-GAAP Financial Measures).
• Net interest margin remains below the 2023 level (4.21% in 2025 vs. 4.43% in 2023) (10-K 2025-12-31, MD&A Financial Performance Highlights).

3. Earnings Assessment

Earnings Trajectory: Mixed

Net income rose 8.7% to $201.4 million in 2025 from $185.3 million in 2024, and diluted EPS increased to $5.31 from $4.83 (10-K 2025-12-31, Consolidated Statements of Operations). Net interest income grew 10.3% to $626.7 million, driven by higher average earning asset balances and lower deposit costs (10-K 2025-12-31, MD&A Net Interest Income). However, noninterest income surged 62% to $113.1 million largely due to a $32.1 million anticipated insurance recovery; excluding that item, noninterest income grew approximately $11.5 million (10-K 2025-12-31, MD&A Noninterest Income). Noninterest expense increased 11.6% to $429.8 million, reflecting higher compensation, deposit costs, and branch acquisition expenses (10-K 2025-12-31, MD&A Noninterest Expense). Provision for credit losses rose to $26.3 million from $21.5 million (10-K 2025-12-31, Consolidated Statements of Operations). Return on average assets was essentially flat at 1.24% vs. 1.25%, and return on average common equity was stable at 10.58% vs. 10.60% (10-K 2025-12-31, MD&A Financial Performance Highlights).

4. Cash Generation Assessment

Cash Trajectory: Mixed

Net cash provided by operating activities declined for the third consecutive year to $193.5 million in 2025 from $247.4 million in 2024 and $268.2 million in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Net cash used in investing activities was $1.08 billion in 2025, reflecting heavy securities purchases ($1.29 billion) and loan growth (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing cash flows were strongly positive, driven by a $1.46 billion increase in total deposits (10-K 2025-12-31, Consolidated Balance Sheets) and a $63.3 million senior note issuance that funded the redemption of subordinated debt (10-K 2025-12-31, MD&A Liquidity and Capital Resources). The net change in cash was a decrease of $82.3 million, leaving cash and cash equivalents at $681.9 million (10-K 2025-12-31, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets grew 10.9% to $17.3 billion, with loans up 5.2% to $11.8 billion and deposits up 11.1% to $14.6 billion (10-K 2025-12-31, Consolidated Balance Sheets). Securities increased 33.6% to $3.7 billion as excess liquidity from the branch acquisition was deployed (10-K 2025-12-31, MD&A Investment Securities). Asset quality deteriorated: nonperforming loans to total loans rose to 0.70% from 0.38%, nonperforming assets to total assets rose to 0.95% from 0.30%, and classified assets to total assets rose to 2.37% from 1.24% (10-K 2025-12-31, MD&A Financial Performance Highlights). The allowance for credit losses to total loans declined to 1.19% from 1.23% (10-K 2025-12-31, MD&A Provision and ACL). Regulatory capital ratios remained well above well-capitalized thresholds but declined modestly: CET1 to 11.6% from 11.8%, Tier 1 to 12.8% from 13.1%, Total capital to 13.9% from 14.6%, and leverage ratio to 10.5% from 11.1% (10-K 2025-12-31, MD&A Capital Resources). Tangible common equity to tangible assets was stable at 9.07% vs. 9.05% (10-K 2025-12-31, MD&A Use of Non-GAAP Financial Measures). Goodwill increased to $417.0 million from $365.2 million due to the branch acquisition (10-K 2025-12-31, Consolidated Balance Sheets).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet trends for 2025 and 2026 (10-Qs for 2025-06-30, 2025-09-30, 2026-03-31, 2026-06-30) were not provided in the filings excerpt.
• Full financing cash flow total for 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows) not explicitly shown in the XBRL excerpt.
• Detailed breakdown of the $32.1 million anticipated insurance proceeds and the associated $8.0 million incremental tax liability beyond the MD&A description.
• Post-2025 quarterly nonperforming loan resolution data (MD&A mentions $17.5 million paid off in Q1 2026 but no filing provided).